Form D · Biotechnology

Dance Biopharm Inc.

Brisbane, CA · CIK 0001596126

Offering snapshot reported Dec 29, 2014 · SEC filing

Reported sold
$5.08M
Offering amount: $15M
Investors reported
52
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 19, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 29, 2014Initial$5,078,000No comparison52SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$1.2M (estimated)
Finders' fees
$0
Form D file number
021-230924
Includes over-allotment option
Units consisting of convertible notes and warrants
Assumes maximum offering sold; includes commissions paid pursuant to over-allotment

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Aegis Capital Corp15007

Source: Form D, filed Dec 29, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Augustine P.Y. Chow, M.D. Director
Donald D. Huffman Director
Joseph J. Krivulka Director
Samantha R. Miller Director, Executive
John S. Patton, Ph.D Director, Executive
Lisa E. Porter, M.D. Executive
Jay S. Skyler, M.D. Director
Adam Stern Director
Greg S. Zante Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
150 North Hill Drive, Suite 24
Brisbane, CA, 94005